Eli Lilly and Company (LLY)

Index:

S&P 100

$ 1,080.36
   
  • Change Today:
    $5.68
  • 52 Week High: $1,109.94
  • 52 Week Low: $625.65
  • Currency: US Dollars
  • Shares Issued: 948.17m
  • Volume: 2,469,097
  • Market Cap: $1,024,365m
  • RiskGrade: 179
  • Beta: 0.70

Latest ShareCast News

Lilly reports solid results from new weight-loss drug trial

By Josh White

Date: Thursday 11 Dec 2025

(Sharecast News) - Eli Lilly reported the first successful phase three results for retatrutide, its experimental once-weekly 'triple agonist' drug, showing unprecedented weight loss alongside major improvements in knee osteoarthritis pain.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

LLY Market Data

Currency US Dollars
Share Price $ 1,080.36
Change Today $ 5.68
% Change 0.53 %
52 Week High $1,109.94
52 Week Low $625.65
Volume 2,469,097
Shares Issued 948.17m
Market Cap $1,024,365m
Beta 0.70
RiskGrade 179

What The Brokers Say

Strong Buy 12
Buy 12
Neutral 7
Sell 0
Strong Sell 0
Total 31
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 02-Jan-2026

Time Volume / Share Price
15:59 59 @ $1,080.47
15:59 40 @ $1,080.49
15:59 40 @ $1,080.49
15:59 72 @ $1,080.46
15:59 158 @ $1,080.49

Top of Page